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68S Abstracts June Supplement 2014increased over time: 11.6% vs 14.9% vs 21.6% (P ¼ .01).
The risk-adjusted LOS index at our institution was signif-
icantly greater (1.25) compared with UHC hospitals
(0.75) except the ﬁrst quarter of FY14, where an
EVAR quality initiative project was introduced, resulting
in equalization of the LOS index (0.70). The greater in-
crease in expected LOS at our institution (26%)
compared with UHC hospitals (7%) partially accounted
for the increased LOS index.
Conclusions: Our study suggests a relationship be-
tween time of EVAR, SOI, complications, and LOS. Atten-
tion to these trends can be used to decrease LOS in an
increasingly complex patient population.Fig.
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Isolated Iliac Artery Aneurysms: The Impact of
Endovascular Repair
Dominique B. Buck1, Thomas Curran1, John C. McCallum1,
Jeremy D. Darling1, Joost A. van Herwaarden2, Frans L.
Moll2, Marc L. Schermerhorn1. 1Beth Israel Deaconess
Medical Center, Boston, Mass; 2University Medical Center
Utrecht, Utrecht, The Netherlands
Objectives: Isolated Iliac artery aneurysms (iIAA) are
rare, but potentially fatal. The impact of recent trends in
the use of advances in imaging and endovascular therapies
(EVIR) on iIAA-associated mortality is unknown.
Methods: We identiﬁed all patients with a primary
diagnosis of IAA in the National Inpatient Sample from
1988 to 2011. We examined trends in management (open
vs EVIR) and overall iIAA related deaths (with or without
repair). We compared in-hospital mortality and complica-
tions for elective open and EVIR from 2000 to 2011.
Results: We identiﬁed 17,102 patients undergoing
iIAA repair from 1988 to 2011; 9016 EVIR and 4933
open repairs electively from 2000 to 2011. Endovascular
surpassed open repair in 2003. Total repairs increased after
introduction of EVIR (P # .001). Total deaths, including
nonoperative, decreased after the introduction of EVIR
(0.54 to 0.24 per 1 million U.S. population, P # .001).
For elective repairs after 2000, EVIR patients were older
(72.4 vs 69.4 years, P ¼ .002) with more prior myocardialinfarction (14.0% vs 11.3%; P < .001) and chronic renal
failure (7.2% vs 3.6%, P < .001). Open repair had signiﬁ-
cantly higher in-hospital mortality (1.8% vs 0.5%, P <
.001), more complications (17.9% vs 6.7%, P < .001)
and a longer length of stay (6.7 vs 2.3 days, P < .001).
Conclusions: Treatment of iIAA has increased with
the introduction of EVIR, with lower perioperative mortal-
ity, despite a higher burden of comorbid illness. Decreasing
iIAA-attributable deaths are likely related to lower elective
mortality and rupture prevention.Author Disclosures: D. B. Buck: Nothing to disclose; T.
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A Comparison of Estimated Outcomes Using the ACS
NSQIP Universal Risk Calculator Tool to Observed
Vascular Procedure Outcomes in a Community
Teaching Hospital
Madian Yahya, Stuart Blackwood, Foula Kontonicolas,
Andrew McGregor, Alan M. Dietzek. Surgery, Danbury
Hospital, Danbury, Conn
Objectives: The National Surgical Quality Improve-
ment Program (NSQIP) universal risk calculator tool was
designed using 1.4 million cases and >2800 different Cur-
rent Procedural Terminology (CPT) codes to estimate
perioperative risk across multiple surgical subspecialties to
guide informed consent. We aimed to test whether periop-
erative risk was accurately estimated for a vascular surgery
cohort in a community teaching hospital setting.
Methods: We performed an IRB-approved retrospec-
tive record review of all consecutive vascular surgery cases
between July 1, 2012, and June 30, 2013. We excluded
CPT codes that were not available in the risk calculator
and reoperations #30 days of the index procedure.
We reviewed all 23 preoperative risk factors present in
the NSQIP tool for each procedure. An estimated
Table. NSQIP Estimated Risk vs Observed Outcomes
Death
Any
complication Pneumonia
Cardiac
complication
Surgical site
infection
Urinary tract
infection VTE Renal failure Return to OR
Serious
complication
3.06% 15.91% 1.84% 2.07% 2.24% 1.41% 0.99% 1.13% 7.92% 12.35%
2.79% 21.73% 2.79% 4.46% 4.46% 2.51% 0.84% 1.95% 9.75% 20.89%
Top Row: estimated risk; Bottom Row: observed outcomes.
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complications was calculated using this tool. We then
compared the cumulative estimated risk to our actual
observed outcomes.
Results: There were 914 consecutive vascular proce-
dures performed in a hospital setting of which only 359
procedures met inclusion criteria. The risk calculator
closely approximated the observed mortality rate and
slightly underestimated the observed outcomes in eight
of the other 10 outcome categories. Alternatively, the
tool signiﬁcantly underestimated the observed risk for
serious complications.
Conclusions: In our study, the NSQIP tool would
have proved useful for purposes of predicting complica-
tions, including death, and informed patient consent. Un-
derestimation of serious complications may reﬂect our
institution speciﬁc outcomes rather than a deﬁciency in
the NSQIP calculator. Studies with large vascular patient
cohorts are necessary to more accurately evaluate this
tool and or create a more comprehensive one speciﬁc to
vascular patients.
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The Effects of Peripheral Arterial Disease on Mortality
in Patients with End-Stage Renal Failure
James Cassuto1, Sateesh Babu2, Igor Laskowski2. 1New
York Medical College, Valhalla, NY; 2Westchester
Medical Center, Valhalla, NY
Objectives: Peripheral arterial disease (PAD) has been
shown to be an independent determinant of all-cause mor-
tality in patients with chronic renal failure (CRF). Howev-
er, a paucity of data exists quantifying the severity of the
interaction between PAD and CRF. Our study was
designed to investigate the presence and signiﬁcance of
PAD on mortality in the setting of CRF.
Methods: We examined 25,664 adult patients listed
for an isolated primary kidney transplant within the United
Network of Organ Sharing database in a retrospective
manner. Multivariate Cox regression was used to model
the relative risk (RR) of 5-year mortality with respect to
PAD and predialysis and dialysis patients. Multivariate lo-
gistic regression was used to model waiting list survival at
30 and 90 days, and at 1, 3, and 5 years to assess the inter-
action between PAD and dialysis. Covariates included age,
gender, ethnicity, primary cause of CRF, coronary artery
disease (CAD), dialysis, and PAD.Results: Relative to patients without PAD and not on
dialysis (PAD-Diale, n ¼ 4860), a 31% increase in the risk
of death was observed in PAD+Diale patients (n ¼ 308), a
95% increase in the risk of death for PAD-Dial+ patients
(n ¼ 19,002), and a 190% increase in the risk of death
for PAD+Dial+ patients (n ¼ 1494). As an independent
covariate, PAD was associated with a 47% increase in the
risk of death, whereas CAD was associated with a 24%
increase. Additionally, the combined effects of PAD and
dialysis on the risk of mortality increased with time.
Conclusions: To our knowledge, this is the ﬁrst study
to demonstrate that in the setting of CRF, PAD is an inde-
pendent risk factor for mortality and increases the risk of
death synergistically with concomitant dialysis therapy.
Additionally, we show that PAD is associated with a greater
RR of mortality than moderate CAD. Early diagnosis and
modiﬁcation of PAD or CRF risk factors in patients with
CRF or PAD, respectively, should be considered in the
management of patients at risk for both.
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The Impact of Vein Harvesting Technique on Wound
Complications and Graft Patency After Infrainguinal
Arterial Bypass
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Objectives: To investigate the impact of vein harvest-
ing technique (VHT) on wound complications and graft
patency after infrainguinal arterial bypass.
Methods: The Vascular Quality Initiative (VQI) data-
base was used to review vein harvest technique of all patients
undergoing single-segment great saphenous vein (GSV)
graft infrainguinal arterial bypass from 2003 to 2013. Pa-
tients were assigned to three groups according to the
VHT used (continous incision, skip incision, and endo-
scopic). Multinomial logistic regression was performed to es-
timate group assignment propensity scores. Propensity score
adjustment was included in multivariate analysis of surgical
site infection (SSI) and graft primary patency.
Results: A total of 5066 patients underwent single-
segment GSV graft infrainguinal bypass. The VHT was
continuous incision in 48.6%, skip incision in 39.7%,
and endoscopic in 12.7%. SSI rates did not differ signif-
icantly among the groups (continuous, 4.7%; skip, 4.0%;
endoscopic, 3.4%; P ¼ .278). On multivariate analysis,
there was no difference in discharge primary patency
among the three groups. The 1-year primary patency
rates were 66.2% for continuous, 68.6% for skip, and
